Neuca (FRA:7HD) Cyclically Adjusted Revenue per Share: €638.01 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:7HD Neuca SA FRA:7HD
94 GF Score
Price €160.40
GF Value €195.27
! 4 Warning Signs
View Full Analysis

What is Neuca Cyclically Adjusted Revenue per Share?

Neuca FRA:7HD +1.01% 94 Cyclically Adjusted Revenue per Share is €638.01 as of Mar. 2026. GuruFocus rates FRA:7HD with a GF Score™ of 94/100 and a GF Value™ of €195.27. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Neuca's adjusted revenue per share for the three months ended in Mar. 2026 was €175.953. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €638.01 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Neuca's average Cyclically Adjusted Revenue Growth Rate was 7.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 8.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 12.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Neuca was 15.10% per year. The lowest was 8.20% per year. And the median was 13.60% per year.

As of today (2026-07-18), Neuca's current stock price is €160.40. Neuca's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €638.01. Neuca's Cyclically Adjusted PS Ratio of today is 0.25.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Neuca was 0.58. The lowest was 0.17. And the median was 0.32.


Neuca  (FRA:7HD) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Neuca's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=160.40/638.01
=0.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Neuca was 0.58. The lowest was 0.17. And the median was 0.32.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Neuca Cyclically Adjusted Revenue per Share Related Terms


Neuca Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Neuca's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neuca Cyclically Adjusted Revenue per Share Chart

Neuca Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 378.97 448.30 528.12 586.73 631.34

Neuca Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 635.08 643.07 618.76 631.34 638.01

FRA:7HD vs MCK, CAH, COR: Cyclically Adjusted Revenue per Share Comparison

For the Medical Distribution subindustry, Neuca's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neuca Cyclically Adjusted PS Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Neuca's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Neuca's Cyclically Adjusted PS Ratio falls into.


FRA:7HD
94GF Score
Neuca SA FRA:7HD
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Neuca Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Neuca's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=175.953/163.0700*163.0700
=175.953

Current CPI (Mar. 2026) = 163.0700.

Neuca Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 75.570 99.552 123.786
201609 76.782 99.064 126.392
201612 83.770 100.366 136.105
201703 91.511 101.018 147.724
201706 80.527 101.180 129.784
201709 81.957 101.343 131.876
201712 89.354 102.564 142.067
201803 95.078 102.564 151.168
201806 78.662 103.378 124.082
201809 85.233 103.378 134.448
201812 90.006 103.785 141.420
201903 98.674 104.274 154.313
201906 100.372 105.983 154.437
201909 99.444 105.983 153.009
201912 105.528 107.123 160.643
202003 137.891 109.076 206.149
202006 97.813 109.402 145.796
202009 117.240 109.320 174.884
202012 122.350 109.565 182.099
202103 114.440 112.658 165.650
202106 115.565 113.960 165.367
202109 125.632 115.588 177.240
202112 131.877 119.088 180.582
202203 140.388 125.031 183.100
202206 132.101 131.705 163.560
202209 142.911 135.531 171.949
202212 148.755 139.113 174.373
202303 153.752 145.950 171.787
202306 146.442 147.009 162.442
202309 150.545 146.113 168.016
202312 149.315 147.741 164.807
202403 159.528 149.044 174.541
202406 152.330 150.997 164.509
202409 159.709 153.439 169.733
202412 162.747 154.660 171.597
202503 168.287 157.021 174.770
202506 162.648 157.509 168.390
202509 174.395 158.000 179.991
202512 173.421 158.320 178.624
202603 175.953 163.070 175.953

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €638.01 mean?
Neuca (FRA:7HD) has a Cyclically Adjusted Revenue per Share of €638.01 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Neuca and its competitors.
Is Neuca's Cyclically Adjusted Revenue per Share too high?
Neuca's current Cyclically Adjusted Revenue per Share is €638.01. Overall, Neuca has a GF Score™ of 94/100, reflecting its overall financial health beyond just this single metric.
How does Neuca's Cyclically Adjusted Revenue per Share compare to MCK and CAH?
Neuca's Cyclically Adjusted Revenue per Share of €638.01 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Distribution company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Distribution industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Neuca and its competitors. Neuca's current Cyclically Adjusted Revenue per Share is €638.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neuca stock overvalued right now?
Neuca (FRA:7HD) has a current Cyclically Adjusted Revenue per Share of €638.01. The stock's GF Value™ is €195.27, compared to a current price of €160.40 — trading 17.9% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €638.01. Neuca's overall GF Score™ is 94/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Neuca (FRA:7HD), the current Cyclically Adjusted Revenue per Share is €638.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Neuca (FRA:7HD) Overvalued in 2026?

Based on GuruFocus' analysis, Neuca stock appears to be undervalued. The current stock price of €160.40 is trading 17.9% below its estimated GF Value™ of €195.27.

Key valuation signals for FRA:7HD:

  • Cyclically Adjusted Revenue per Share: €638.01
  • GF Value™: €195.27 vs. price of €160.40 (17.9% below fair value)
  • GF Score™: 94/100 with 4 warning signs

No single metric tells the full story. See the FRA:7HD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Neuca Business Description

Other Exchanges NEU:Poland
Address ul. Forteczna 35‑37, Torun, POL, 87-100
Neuca SA is a wholesale distributor of pharmaceuticals in Poland. The company's segment includes Pharmacy wholesale; Manufacture of pharmaceuticals; Outpatient medical care clinics; Clinical trials and Insurance activities. It generates maximum revenue from the Pharmacy wholesale segment.
94GF Score

Get the complete analysis for FRA:7HD

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€160.40
Price
€195.27
GF Value